Physician profile
David C Wang
NPI 1649491440
$13,499.30
in general payments reported to CMS, 2019-2025
43 companies · $978 in 2025
The $978 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,840 · 2020: $5,010 · 2021: $1,064 · 2022: $1,429 · 2023: $1,237 · 2024: $942 · 2025: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,156.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,773.43 | 2019-2025 | Aveir, Accent, Merlin@Home |
| Medtronic Vascular, INC. | $1,535.52 | 2019 | |
| Biosense Webster, INC. | $1,239.31 | 2019-2025 | Carto 3, Qdot Micro Catheter |
| Pfizer INC. | $690.10 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $665.00 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $425.51 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $393.59 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor |
| Amgen INC. | $383.84 | 2019-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $313.07 | 2022-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $254.55 | 2019-2025 | Opsumit, Uptravi |
| Medtronic, INC. | $237.03 | 2023-2024 | Adapta, Micra, Venaseal |
| Novartis Pharmaceuticals Corporation | $213.16 | 2019-2025 | |
| Altathera Pharmaceuticals LLC | $194.39 | 2021-2023 | Sotalol Hydrochloride |
| United Therapeutics Corporation | $151.68 | 2019-2025 | Tyvaso, Tyvaso |
| Cardiofocus, INC. | $131.83 | 2019 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.